Heart Valve Replacement
Heart Valve Replacement in Turkey
Heart valve replacement in Turkey treats selected severe valve disease when repair, medication, or another intervention cannot meet the clinical objective. Replacement may involve mechanical or biological prostheses, while selected aortic valve patients can undergo transcatheter treatment. Choosing a valve requires lifetime planning rather than focusing only on the operation.
When Is Heart Valve Replacement Considered Instead of Valve Repair?
Heart valve replacement is considered when preserving the native valve cannot provide an appropriate and durable treatment strategy. Repair can remain preferable for selected valve diseases when anatomy allows a reliable reconstruction. Mitral and tricuspid disease often raise particularly important repair-versus-replacement questions. Other valves may require replacement because of extensive calcification, degeneration, infection-related damage, or unsuitable anatomy. Echocardiography helps define the mechanism and severity before intervention. The 2025 ESC/EACTS guideline emphasizes Heart Team assessment for complex valve decisions. Patients should therefore ask whether repair was considered and why replacement better matches their specific valve anatomy.

Which Replacement Heart Valve Types Can Be Used?
Replacement valves mainly include mechanical and biological prostheses, and each creates different long-term treatment considerations.
Mechanical valves: Durable manufactured prostheses usually require lifelong anticoagulation with a vitamin K antagonist.
Biological valves: Tissue prostheses avoid lifelong valve-related anticoagulation for many patients but can deteriorate structurally over time.
Transcatheter valves: Biological prostheses can be delivered through catheters for selected aortic and other valve interventions.
Specialized alternatives: Selected patients may require other surgical strategies according to anatomy and underlying disease.
Valve selection should consider age, bleeding risk, future procedures, pregnancy plans, preferences, anatomy, and expected longevity.
How Do Mechanical and Biological Heart Valves Differ?
Mechanical and biological valves differ mainly in durability, anticoagulation requirements, and the possibility of future structural deterioration. Mechanical prostheses are designed for long-term durability but create an ongoing clotting risk. Most recipients therefore require lifelong anticoagulation. Biological valves use animal or human tissue and generally have lower long-term thrombogenicity. However, tissue valves can undergo structural valve deterioration and may eventually require another intervention. The choice is not simply based on age. Bleeding risk, medication adherence, pregnancy considerations, lifestyle, anatomy, and expected future procedures also matter. Shared decision-making is therefore central to modern prosthetic valve selection.
Is Surgical Valve Replacement the Same as TAVI or TAVR?
No, surgical valve replacement and TAVI use different access methods even though both can replace a diseased aortic valve. Surgical replacement generally removes the diseased valve and implants a prosthesis during cardiac surgery. TAVI, also called TAVR, advances a biological valve through a catheter. The transcatheter valve expands within the existing diseased aortic valve. Current 2025 European guidance considers age, anatomy, surgical risk, vascular access, and lifetime strategy when selecting an approach. TAVI is therefore not simply a smaller version of surgery. Younger patients and complex anatomy can create different reasons for surgical valve replacement.
Why Does Lifetime Valve Planning Matter Before Replacement?
Lifetime valve planning matters because the first prosthesis can influence anticoagulation, future interventions, and later access to cardiac structures. A biological valve may eventually deteriorate and require repeat treatment. Selected patients can later undergo valve-in-valve procedures, but anatomical feasibility is not guaranteed. Mechanical valves reduce concern about structural tissue degeneration but require continuing anticoagulation. Future coronary access can also matter after transcatheter aortic valve procedures. Younger patients may face several valve-related decisions during their lifetime. The 2025 ESC/EACTS guideline therefore emphasizes individualized and patient-centered planning rather than choosing a prosthesis solely for the immediate operation.
What Does Anticoagulation Involve After Mechanical Valve Replacement?
Mechanical valve replacement generally requires lifelong vitamin K antagonist anticoagulation to reduce prosthetic valve thrombosis and embolic complications. Anticoagulation intensity depends on valve type, position, and individual thromboembolic factors. Regular INR monitoring therefore becomes part of long-term care. The 2025 ESC/EACTS guidance emphasizes patient education and individualized antithrombotic management. Selected trained patients may also use INR self-monitoring or self-management under appropriate supervision. Anticoagulant treatment creates bleeding risks alongside clot-prevention benefits. Patients should never change or stop therapy independently. International patients need a reliable INR monitoring and prescribing pathway after returning to their home country.
Can Heart Valve Replacement Be Performed Through Smaller Incisions?
Selected heart valve operations can use smaller surgical incisions, but minimally invasive access is not appropriate for every patient. Turkish public cardiac centers document small-incision aortic and mitral valve procedures. Selected centers also document robotic mitral repair and replacement. These approaches still require complete cardiac surgical planning. Small incisions do not remove risks related to cardiopulmonary bypass, valve implantation, bleeding, rhythm disturbances, or other complications. Previous operations, aortic disease, chest anatomy, combined procedures, and emergency conditions can influence access. Patients should therefore evaluate the clinical reason for a proposed approach rather than assuming smaller access is inherently superior.
Which Problems Require Monitoring After Heart Valve Replacement?
Heart valve replacement requires continuing monitoring for prosthesis function, infection, clotting, bleeding, rhythm problems, and cardiac performance.
Valve dysfunction: Prosthetic valves can develop obstruction, regurgitation, thrombosis, or structural deterioration.
Endocarditis: Infection involving a prosthetic valve requires urgent specialist assessment.
Anticoagulation problems: Mechanical-valve patients can experience bleeding or thromboembolic complications when anticoagulation becomes inappropriate.
Rhythm disturbances: Cardiac surgery can be followed by atrial or other rhythm abnormalities.
Heart-function changes: Symptoms can reflect ventricular dysfunction or another cardiovascular condition.
New breathlessness, fainting, fever, chest symptoms, or unexplained functional decline should prompt appropriate clinical assessment.
Why Does Dental Care Matter After Prosthetic Heart Valve Replacement?
Dental care matters because prosthetic valve recipients have increased concern regarding serious infective endocarditis complications. Good oral hygiene and regular dental care help reduce sources of oral infection. Current American Heart Association information places prosthetic heart valves among conditions with highest endocarditis complication risk. Antibiotic prophylaxis may be recommended before certain dental procedures involving gums, tooth roots, or oral mucosal perforation. It is not automatically required before every dental or medical procedure. Patients should tell dentists about their valve prosthesis. Their cardiologist should guide prophylaxis according to the planned procedure and individual medical circumstances.
What Should International Patients Prepare Before Valve Replacement in Turkey?
International patients should provide complete valve imaging, cardiovascular history, medication information, and previous procedural records before traveling to Turkey. Recent echocardiography should document valve anatomy, severity, ventricular function, and associated findings. CT or coronary angiography can be relevant for selected patients. Previous CABG, PCI, TAVI, valve surgery, pacemaker, and ablation reports should also be supplied. Patients should list anticoagulants and other cardiovascular medicines. Kidney disease, bleeding history, previous endocarditis, and dental infections also require disclosure. The receiving Heart Team should identify additional investigations before travel whenever practical and establish postoperative follow-up arrangements.
How Can International Patients Verify a Heart Valve Surgery Provider in Turkey?
International patients can verify health-tourism authorization through official records published by Turkey's Ministry of Health. The current provider page is dated July 28, 2026. Authorization confirms regulatory eligibility for international health-tourism services, not suitability for an individual valve operation. Patients should separately confirm cardiac surgery and required valve services. A Ministry notice dated May 13, 2026 also defines accreditation requirements for specified authorized facilities. Covered hospitals must complete TÜSKA accreditation by December 31, 2026. Neither authorization nor accreditation guarantees clinical outcomes. Individual treatment still requires diagnostic assessment, informed consent, and appropriate Heart Team planning.
Heart Valve Replacement in Turkey Cost 2026: What Affects the Total Cost?
Heart valve replacement in Turkey has no single 2026 cost because clinical and procedural requirements vary between patients. This page therefore provides no fixed treatment price. Costs can depend on the affected valve, prosthesis type, surgical approach, and required preoperative imaging. Mechanical, biological, surgical, and transcatheter pathways involve different devices and resources. Anesthesia, intensive care, hospitalization, laboratory monitoring, and additional cardiac procedures can also influence the financial plan. Complications or extended follow-up can create further requirements. International patients should request an individualized written quotation after clinical review, with prostheses, services, follow-up, and exclusions clearly identified.
This content provides general medical information and does not recommend valve replacement, a particular prosthesis, healthcare provider, or clinical outcome. Heart valve treatment requires individualized cardiovascular assessment.
Last updated: August 14, 2026
Sources
https://www.escardio.org/guidelines/clinical-practice-guidelines/all-esc-practice-guidelines/valvular-heart-disease/
https://www.escardio.org/communities/working-groups/cardiovascular-pharmacotherapy/scientific-documents-and-publications/Commented-articles/a-spotlight-on-antithrombotic-aspects-of-the-2025-esc-eacts-guidelines-on-valvular-heart-disease/
https://www.escardio.org/communities/councils/cardiology-practice/scientific-documents-and-publications/ejournal/volume-20/prosthetic-heart-valves-part-1-selection/
https://www.escardio.org/communities/councils/cardiology-practice/scientific-documents-and-publications/ejournal/volume-20/prosthetic-heart-valves-part-4-complications-and-dysfunction-pregnancy/
https://www.heart.org/en/health-topics/heart-valve-problems-and-disease/understanding-your-heart-valve-treatment-options/types-of-replacement-heart-valves
https://www.heart.org/en/health-topics/heart-valve-problems-and-disease/understanding-your-heart-valve-treatment-options/options-for-heart-valve-replacement
https://www.heart.org/en/health-topics/infective-endocarditis
https://mehmetakifersoyeah.saglik.gov.tr/TR-60559/robotik-cerrahi.html
https://mehmetakifersoyeah.saglik.gov.tr/TR%2C59914/ameliyathane.html
https://etliksehir.saglik.gov.tr/TR-828342/klinik-hakkinda.html
https://shgmturizmdb.saglik.gov.tr/EN-69289/healthcare-providers-with-international-health-tourism-authorization-certificates.html
https://shgmturizmdb.saglik.gov.tr/EN-108974/regulation-on-international-health-tourism-and-tourist-health.html
https://shgmturizmdb.saglik.gov.tr/TR-117812/saglik-turizmi-yetki-belgesine-sahip-saglik-tesislerinin-dikkatine.html
https://antalyaism.saglik.gov.tr/TR-366500/saglik-hizmetlerinde-tanitim-ve-bilgilendirme--faaliyetleri-hakkinda-yonetmelik.html
